BACKGROUND AND OBJECTIVES: When monotherapy is inadequate for blood pressure control, the next step is either to continue monotherapy in increased doses or to add another antihypertensive agent. However, direct comparison of double-dose monotherapy versus combination therapy has rarely been done. The objective of this study is to compare 10 mg of amlodipine with an amlodipine/valsartan 5/160 mg combination in patients whose blood pressure control is inadequate with amlodipine 5 mg. SUBJECTS AND METHODS: This study was conducted as a multicenter, open-label, randomized controlled trial. Men and women aged 20-80 who were diagnosed as having hypertension, who had been on amlodipine 5 mg monotherapy for at least 4 weeks, and whose daytime mean systolic blood pressure (SBP) ≥135 mmHg or diastolic blood pressure (DBP) ≥85 mmHg on 24-hour ambulatory blood pressure monitoring (ABPM) were randomized to amlodipine (A) 10 mg or amlodipine/valsartan (AV) 5/160 mg group. Follow-up 24-hour ABPM was done at 8 weeks after randomization. RESULTS: Baseline clinical characteristics did not differ between the 2 groups. Ambulatory blood pressure reduction was significantly greater in the AV group compared with the A group (daytime mean SBP change: -14±11 vs. -9±9 mmHg, p<0.001, 24-hour mean SBP change: -13±10 vs. -8±8 mmHg, p<0.0001). Drug-related adverse events also did not differ significantly (A:AV, 6.5 vs. 4.5%, p=0.56). CONCLUSION: Amlodipine/valsartan 5/160 mg combination was more efficacious than amlodipine 10 mg in hypertensive patients in whom monotherapy of amlodipine 5 mg had failed.
Amlodipine* ; Blood Pressure ; Blood Pressure Monitoring, Ambulatory ; Female ; Follow-Up Studies ; Humans ; Hypertension ; Male ; Random Allocation

BACKGROUND AND OBJECTIVES: The prognostic value of biochemical markers and the resolution of ST-segment elevation on electrocardiogram are well established. However, how a combination of these two tools affects the evaluation of risk stratification has not yet been evaluated. SUBJECTS AND METHODS: Between January 2006 and June 2008, 178 consecutive patients treated with primary percutaneous coronary interventions after ST-segment elevation myocardial infarctions (STEMI) were analyzed at two coronary care units. Patients were divided into the following three groups according to ST-segment resolution: complete (> or =70% depression of the elevated ST-segment, n=63), partial (30% to 70%, n=90), and incomplete (<30%, n=25). Demographic data, including history, electrocardiography, biochemical markers, initial ejection fraction, and angiographic findings were also evaluated. RESULTS: There were 7 deaths, 3 repeated myocardial infarctions, and 17 readmissions for worsening heart failure during six months of follow-up. In a multivariate analysis to predict clinical outcomes, ejection fraction {hazard ratio (HR): 0.83 (0.76-0.91), p<0.01}, high-sensitivity C-reactive protein {HR: 1.15 (1.05-1.26), p<0.05}, and the degree of ST-segment resolution {HR: 0.96 (0.93-0.09), p<0.05} were independently associated with clinical outcomes. According to the Cox-proportional hazards model, the addition of ST-segment resolution markedly improved the prognostic utility of the model containing biochemical markers and ejection fraction. CONCLUSION: Assessment of biomarkers upon admission and ST-segment resolution are strong predictors of clinical outcomes. The combination of these data provides additive information about prognosis at an early point in the disease progression and further improves risk stratification for STEMI.
Biomarkers ; C-Reactive Protein ; Coronary Care Units ; Depression ; Disease Progression ; Electrocardiography ; Follow-Up Studies ; Heart Failure ; Humans ; Multivariate Analysis ; Myocardial Infarction ; Percutaneous Coronary Intervention ; Prognosis ; Proportional Hazards Models

OBJECTIVES: To develop effective ways of sharing patients' medical information, we developed a new medical information exchange system (MIES) based on a registry server, which enabled us to exchange different types of data generated by various systems. METHODS: To assure that patient's medical information can be effectively exchanged under different system environments, we adopted the standardized data transfer methods and terminologies suggested by the Center for Interoperable Electronic Healthcare Record (CIEHR) of Korea in order to guarantee interoperability. Regarding information security, MIES followed the security guidelines suggested by the CIEHR of Korea. This study aimed to develop essential security systems for the implementation of online services, such as encryption of communication, server security, database security, protection against hacking, contents, and network security. RESULTS: The registry server managed information exchange as well as the registration information of the clinical document architecture (CDA) documents, and the CDA Transfer Server was used to locate and transmit the proper CDA document from the relevant repository. The CDA viewer showed the CDA documents via connection with the information systems of related hospitals. CONCLUSIONS: This research chooses transfer items and defines document standards that follow CDA standards, such that exchange of CDA documents between different systems became possible through ebXML. The proposed MIES was designed as an independent central registry server model in order to guarantee the essential security of patients' medical information.
Delivery of Health Care ; Electronic Health Records ; Electronics ; Electrons ; Information Systems ; Korea

Acute coronary syndrome (ACS) represents a broad spectrum of ischemic myocardial events, including unstable angina, non-ST elevation myocardial infarction, and acute ST elevation myocardial infarction, which are associated with high morbidity and mortality. Early diagnosis and risk stratification are essential for initiation of optimal medical and invasive management. Randomized clinical trials over the past decade have revolutionized the care of patients with ACS. Therapeutic measures consist of administration of aggressive antiplatelet, antithrombotic, and antiischemic agents. In addition, patients with high-risk features, notably positive troponin, ST segment changes, and diabetes, benefit from early invasive intervention as compared to conservative strategies. Lifestyle interventions, modification of risk factor profile, and long-term medical treatment are of pivotal importance in reducing the long-term risk of recurrence.
Acute Coronary Syndrome ; Angina, Unstable ; Anticoagulants ; Early Diagnosis ; Humans ; Life Style ; Myocardial Infarction ; Platelet Aggregation Inhibitors ; Recurrence ; Risk Factors ; Secondary Prevention ; Troponin

Purulent pericarditis is a rare, life-threatening condition and usually involves the whole pericardium. However only few cases have been reported in which a loculated pericardial abscess occurred from purulent pericarditis. The prevalence of acute pericarditis due to bacteria was 6%. Purulent pericarditis due to anaerobic bacteria has been reported less frequently than aerobic bacteria. There was no report about purulent pericarditis due to Bacteroides fragilis in Korea until now. So we report the first case of pericardial abscess due to B. fragilis in 59 year old Korean male with history of chronic renal failure and hemodialysis, that was complicated with pericardial tamponade.
Abscess* ; Bacteria ; Bacteria, Aerobic ; Bacteria, Anaerobic ; Bacteroides fragilis* ; Bacteroides* ; Cardiac Tamponade* ; Humans ; Kidney Failure, Chronic ; Korea ; Male ; Middle Aged ; Pericarditis ; Pericardium ; Prevalence ; Renal Dialysis

Purulent pericarditis is a rare, life-threatening condition and usually involves the whole pericardium. However only few cases have been reported in which a loculated pericardial abscess occurred from purulent pericarditis. The prevalence of acute pericarditis due to bacteria was 6%. Purulent pericarditis due to anaerobic bacteria has been reported less frequently than aerobic bacteria. There was no report about purulent pericarditis due to Bacteroides fragilis in Korea until now. So we report the first case of pericardial abscess due to B. fragilis in 59 year old Korean male with history of chronic renal failure and hemodialysis, that was complicated with pericardial tamponade.
Abscess* ; Bacteria ; Bacteria, Aerobic ; Bacteria, Anaerobic ; Bacteroides fragilis* ; Bacteroides* ; Cardiac Tamponade* ; Humans ; Kidney Failure, Chronic ; Korea ; Male ; Middle Aged ; Pericarditis ; Pericardium ; Prevalence ; Renal Dialysis

BACKGROUND AND OBJECTIVES: We investigated whether prehypertensives (PHs) exhibit more prevalent electrocardiographic and echocardiographic left ventricular hypertrophy (ECG LVH) and if they are are more associated with impaired left ventricular (LV) diastolic function than are normotensives (NTs). SUBJECTS AND METHODS: A total of 608 subjects> or = 40 years of age with normal BP (SBP<120 mmHg and DBP<80 mmHg, n=335) and PH (n=273) and who were without a history of hypertension, diabetes and any other known cardiovascular diseases underwent blood sampling for obtaining the lipid profile, and they also underwent 12-lead electrocardiography and echocardiography. RESULTS: Compared with the NTs, the PHs had significantly higher Sokolow-Lyon and Cornell voltage for ECG LVH, and they ahd a higher prevalence of ECG LVH (men: 16.9% vs 5.9%, women: 2.0% vs 1.0%, respectively). The PHs had a more increased left ventricular mass index (LVMI, Men: 118.1+/-24.4 g/m2 vs 102.0+/-19.1 g/m2, p=0.02; Women: 117.5+/-26.4 g/m2 vs 101.9+/-30.7 g/m2, p=0.02) and a more decreased LV diastolic function (E/A, Men: 1.14+/-0.6 vs 1.30+/-0.4, p=0.03; Wemen: 1.11+/-0.6 vs 1.25+/-0.5, p=0.03) on echocardiography than the NTs. CONCLUSION: The PHs were associated with a higher prevalence of ECG LVH and a more increased LVMI on echocardiography than that of the NTs. Therefore, we should pay earlier attention to diagnose and screen the pre-hypertensive group.
Cardiovascular Diseases ; Echocardiography ; Electrocardiography ; Female ; Humans ; Hydrogen-Ion Concentration ; Hypertension ; Hypertrophy, Left Ventricular* ; Male ; Prevalence

BACKGROUND: Aldosterone acts as a non-hemodynamic factors on the hypertensive heart regarding sodium retension or myocardial fibrosis. To elucidate whether aldosterone is associated with the specific left ventricular geometry or not, we investigated the relationship between the upright serum aldosterone levels and the echocardiographicleft ventricular structure in the essential hypertension patients never treated. METHODS: Echocardiographic indices included M-mode measured left ventricular mass index (LVMI), relative wall thickness (RWT). Aldosterone is measured by Radioimmunoassay for the serum withdrawn from the subjects at least 3 hours upright position. 63 patients and 20 normal control subjects were evaluated. RESULTS: 1) 84.1% (63/53) of cases showed left ventricular hypertrophy. 7 patients showed normal LVMI, 3 patients showed concentric remodeling geometry. 19 patients had concentric left ventricular hypertrophy (LVH). 34 patients had eccentric LVH. 2) The serum aldosterone level has negative correlation with the RWT (r=-0.27, p=0.03) but not with LVMI (r=0.08, p=NS). There was difference among groups (ANOVA, F=0.009). Serum aldosterone is higher in eccentric LVH group than in concentric LVH group (10.5+/-1.2 ng/dL vs 5.2+/-0.6 ng/dL, p=0.0001) and than in control group (10.5+/-1.2 ng/dL vs 6.6+/-0.8 ng/dL, p=0.01). CONCLUSION: In this study, we observed that the serum aldosterone level was not correlated with the LVMI but with RWT negatively so that eccentric LVH group showed higher serum aldosterone levels than control group and concentric LVH group.
Aldosterone* ; Echocardiography ; Fibrosis ; Heart ; Humans ; Hypertension* ; Hypertrophy, Left Ventricular ; Radioimmunoassay ; Sodium

BACKGROUND: An unusual form of hypertrophic cardiomyopathy localized to the left ventricular apex has racial differences in phenotypic expression between many Japanese reports and most reports from outside Japan. In Japanese patients follow up study of apical hyertrophy has shown benign clinical course without demonstrable genetic transmission, but other ethnic patients with this variant was clinically different from Japanese patients. The purpose of this study was to evaluate the clinical course and the progression of hypertrophy of apical hyper- trophic cardiomyopathy by echocardiography and to define the relationship between the severity of apical hypertrophic cardiomyopathy and the clinical course. METHODS: Between June 1990 and August 1996, 35 out of 53 patients with apical hypertrophic cardiomyopathy diagnosed by echocardiography were studied. In 26 out of 35 patients, two- dimensional echocardiography and EKG were obtained at initial visit and follow up. We analyzed the sum of S wave in lead Vl and R wave in lead VS(mm) and T wave negativity in lead V4 on EKG. Measured echocardiographic parameters were apical thickness and apical cross-sectional area of left ventricle at end-diastole in apical tour chamber view, anteroposterior left atrial dirnension at end systole in parasternal short axis view and pulsed-wave Doppler pattern of transmitral inflow. RESULTS: 1) Mean age at presentation was 57.9+8.3 years(range 37 to 72). Mean follow up duration of echocardiography and EKG were 29.5+/-13.5 months and 27.7+ -1.4 months, respectively. 2) Eleven(31%) out of 35 patients were asymptomatic at initial presentation. In the remaining 24 patients, major symptoms included atypical chest pain(n=7), angina (n=11), dyspnea(n=12), palpitation(n=4) and fatigue(n=l), During follow-up, symptoms aggravated in 5/35(14%), no change in 22/35(63%) and allenated in 8/35(23%). The clinical event during follow up was transient ischemic attack in 1 patient, syncope in 1 patient and death in 1 patient with cerebral infarction and upper gastrointestinal bleeding. 3) Electrocardiography revealed normal sinus rhphm in 24 patients and atrial fibrillation in 2 patients at initial presentation. Paroxysmal atrial fibrillation was observed in 1 patient during follow up period at 24 hours Holter monitoring. Negative T wave amplitude was increased from 11.5+/-5.5 to 13.1+/-6.5mm(p<0.05), however the sum of SV, and RV, did not change significantly. 4) The apical thickness and apical cross-sectional area changed over time, frorn 19.9+/- 3.2 to 21.8+/-4.lmm(p<0.005) with interobservers difference of 2.3+/-1.2mm and from 11.4+/-2.4 to 12.5+/-3.1cm(p<0.05) with interobservers difference of 1.9+/-1.5cm, respectively. Left atrial dimension increased from 43.5+/-6.6 to 46.2+/-6.1mm(p<0.005). Transmitral inflow revealed norrnal E/A ratio and deceleration time of 150~ 40msec in 11 patients with changed to relaxation abnormalities in three and pseudonormalization in ovo and relaxation abnormalities in 14 patients with changed to pseudonormalization in three at follow-up. CONCLUSIONS: Patients with apical hypertrophic cardiomyopathy have relatively favorable prognosis during follow up period without any significant clinical event and symptomatic deterioration. T wave negativity on EKG and left atrial dimension on echocardiographic examination were increased during follow up, but these parameters were not associated with clinical presentation.
Asian Continental Ancestry Group ; Atrial Fibrillation ; Axis, Cervical Vertebra ; Cardiomyopathies ; Cardiomyopathy, Hypertrophic* ; Cerebral Infarction ; Deceleration ; Echocardiography* ; Electrocardiography ; Electrocardiography, Ambulatory ; Follow-Up Studies* ; Heart Ventricles ; Hemorrhage ; Humans ; Hypertrophy ; Ischemic Attack, Transient ; Japan ; Prognosis ; Relaxation ; Syncope ; Systole ; Thorax

BACKGROUND AND OBJECTIVES: QT dispersion (QTd) represents the inhomogeneity of ventricular repolarization and has been suggested to predict ventricular arrhythmia in patients with coronary artery disease (CAD). This study investigates the short-term effect of percutaneous transluminal coronary angioplasty (PTCA) on QTd in patients with CAD and no history of previous myocardial infarct. MATERIALS AND METHODS: In 84 angina patients (65 men and 19 women, mean age of 58.3+/-9.0 yeras) who underwent successful PTCA of single coronary artery, ECG was checked in baseline, immediate, 1day and 1 month after PTCA. QTd and corrected QTd (c-QTd) were measured in these ECGs by digitizer. RESULTS: PTCA was performed at left anterior descending artery (LAD) in 56, left circumflex artery (LCx) in 12 and right coronary artery (RCA) in 16 patients. Mean and standard error of QTd (c-QTd) at baseline, immediate, 1day and 1month after PTCA was 51.3+/-4.2 (50.7+/-4.1), 54.2+/-4.5 (52.8+/-4.5), 47.7+/-4.3 (48.5+/-4.8) and 36.3+/-4.5 (37.5+/-4.6)msec, respectively. QTd and c-QTd significantly decreased at 1 month following PTCA. The difference was more prominent in pateints with LAD lesion than LCx or RCA lesion and independent of gender, severity of stenosis and use of beta-blockers. CONCLUSION: QTd decreases in CAD patients with no history of myocardial infarct at 1 month following successful PTCA. This may facilitate a favorable recovery from inhomogenous repolarization. These findings call for long-term follow-up of QTd and the incidence of ventricular tachyarrhythmias and sudden death following successful PTCA.
Angioplasty, Balloon, Coronary ; Arrhythmias, Cardiac ; Arteries ; Constriction, Pathologic ; Coronary Artery Disease ; Coronary Vessels ; Death, Sudden ; Electrocardiography ; Female ; Humans ; Incidence ; Male ; Myocardial Infarction ; Tachycardia